MADISON HEIGHTS, Mich.
March 5, 2012
/PRNewswire/ -- InfuSystem Holdings, Inc. (NYSE Amex: INFU) ("Company"), the leading national provider of infusion pumps and related services, today announced that the previously announced request by Kleinheinz Capital Partners, Meson Capital Partners, Boston Avenue Capital and certain affiliates (the "Kleinheinz Dissident Group") to call a special meeting has been determined to be valid based upon a report by an independent inspector of elections.
In accordance with the Company's bylaws, the InfuSystem Board of Directors will set a meeting date for the special meeting, which will be held no later than
, 2012. Further details regarding the meeting will be included in the Company's proxy statement, which InfuSystem will mail to stockholders of record in advance of the special meeting.
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. is the leading provider of infusion pumps and related services to hospitals, oncology practices and other alternate site healthcare providers. Headquartered in
Madison Heights, Michigan
, the company delivers local, field-based customer support, and also operates Centers of Excellence in
. The company's stock is traded on the NYSE Amex under the symbol INFU.
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those predicted by such forward-looking statements. These risks and uncertainties include general economic conditions, as well as other risks, detailed from time to time in the company's publicly filed documents.
Additional Information and Where to Find It
In connection with the special meeting, InfuSystem Holdings, Inc. will file a proxy statement with the Securities and Exchange Commission (the "SEC"). STOCKHOLDERS ARE URGED TO READ THE PROXY STATEMENT AND OTHER RELEVANT MATERIALS WHEN THEY BECOME AVAILABLE BECAUSE THEY CONTAIN IMPORTANT INFORMATION. InfuSystem and its directors and executive officers may be deemed to be participants in the solicitation of proxies in connection with the special meeting. Stockholders may obtain additional information regarding such participants and their interests from the proxy statement, when available, and from InfuSystem's periodic reports filed with the SEC. The periodic reports and proxy statement and other relevant documents will be available at no charge at the web site of the SEC at
Tel: (800) 962-9656
, Wilkinson Brimmer KatcherTel: (212) 355-4449
SOURCE InfuSystem Holdings, Inc.